Former Rolls Royce chief joins Protium as green hydrogen firms gears up to accelerate activity

Former Rolls Royce chief joins Protium as green hydrogen firms gears up to accelerate activity

Rolls Royce’s former chief executive has joined the ranks of Protium as the green hydrogen firm makes key board appointments amidst its acceleration in activity.

In addition to Sir John Rose joining Protium’s advisory board, Mikael Ericson, former group chief executive of Swedish-listed credit management and investment firm Intrum, has joined Protium’s board to advise the UK company on international opportunities and financing.

David Scott, co-founder and Chairman of Tribe Impact Capital, a UK-based impact investment and wealth management firm, also joins Protium’s advisory board.

The three appointments coincide with the completion of Protium’s latest funding round to support its growth trajectory and commercialisation strategy.

“I am delighted to welcome Mikael, John and David to our board and advisory board at such an exciting time for the business,” said Chris Jackson, founder and CEO of Protium.

“To secure their support and complete this latest round of funding further demonstrates the growing interest in not only green hydrogen as an emerging and viable energy solution, but also in the Protium proposition more broadly.

“At a time where taking action is essential, I am thrilled to have the support of our investors and specialists so we can accelerate our activity.”

Jackson stepped down as chair of the UK Hydrogen & Fuel Cell Association (UK HFCA) last month over the UK Government’s focus on blue hydrogen.

“I believe passionately that I would be betraying future generations by remaining silent on that fact that blue hydrogen is at best an expensive distraction, and at worst a lock-in for continued fossil fuel use that guarantees we will fail to meet our decarbonisation goals,” he said in a statement at the time.

Read more: Chris Jackson steps down as UK HFCA chair

Sign up to our newsletter

Get all the latest hydrogen news, views and developments straight to your inbox.

Sign up to H2 View’s weekly bulletin today to ensure you don’t miss out

About the author
Related Posts
Loading feed...
Please wait...